Spots Global Cancer Trial Database for rare disease

Every month we try and update this database with for rare disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome	NCT00004832	Lambert-Eaton M...	3,4-diaminopyri...	18 Years -	FDA Office of Orphan Products Development
Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors	NCT00004659	Brain Neoplasms	irradiation radiosurgery	0 Years -	Office of Rare Diseases (ORD)
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome	NCT00004311	Acanthosis Nigr... Polycystic Ovar...	leuprolide acet... spironolactone	0 Years -	Office of Rare Diseases (ORD)
Randomized Study of Hormonal Regulation of Infantile Hemangioma	NCT00004436	Hemangioma	leuprolide prednisone	1 Month - 8 Months	FDA Office of Orphan Products Development
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome	NCT00005104	Polycystic Ovar... Hyperinsulinism	clomiphene citr... metformin	18 Years - 40 Years	National Center for Research Resources (NCRR)
Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors	NCT02938793	Cancer Rare Disease	Durvalumab Tremelimumab	18 Years -	Prisma Health-Upstate
Medication Adherence and Non-adherence in Adults With Rare Disease	NCT04541875	Cystic Fibrosis Hemophilia A Hemophilia B Idiopathic Pulm... Myasthenia Grav... Sickle Cell Dis...	MAR-Scale	18 Years -	Xperiome
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease	NCT00014742	Dupuytren's Con...	collagenase	18 Years -	FDA Office of Orphan Products Development
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome	NCT00005104	Polycystic Ovar... Hyperinsulinism	clomiphene citr... metformin	18 Years - 40 Years	National Center for Research Resources (NCRR)
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease	NCT00004409	Dupuytren's Con...	collagenase	18 Years -	FDA Office of Orphan Products Development
Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome	NCT00005104	Polycystic Ovar... Hyperinsulinism	clomiphene citr... metformin	18 Years - 40 Years	National Center for Research Resources (NCRR)
International Registry of Congenital Portosystemic Shunt (IRCPSS)	NCT06041906	Congenital Port...	Shunt Closure	1 Day -	University Hospital, Geneva
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease	NCT00004941	Crohn's Disease	monoclonal anti...	18 Years - 65 Years	FDA Office of Orphan Products Development
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease	NCT00014742	Dupuytren's Con...	collagenase	18 Years -	FDA Office of Orphan Products Development
Randomized Study of Hormonal Regulation of Infantile Hemangioma	NCT00004436	Hemangioma	leuprolide prednisone	1 Month - 8 Months	FDA Office of Orphan Products Development
The Sarcoma Biology and Outcome Project	NCT04758325	Sarcoma Malignant Mesen... Sarcoma of Bone...		12 Years -	University Hospital Heidelberg
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis	NCT00004682	Myasthenia Grav...	immune globulin	15 Years -	FDA Office of Orphan Products Development
International Rare Brain Tumor Registry	NCT05697874	Astroblastoma BCOR ITD Sarcom... CNS Sarcoma Unclassified Tu...		- 45 Years	Children's National Research Institute
Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome	NCT00005654	Hyperinsulinism Polycystic Ovar...	clomiphene citr... metformin	18 Years - 40 Years	Office of Rare Diseases (ORD)
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease	NCT00004941	Crohn's Disease	monoclonal anti...	18 Years - 65 Years	FDA Office of Orphan Products Development
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2	NCT00004437	Neurofibromatos...	Multichannel Au...	12 Years -	FDA Office of Orphan Products Development
International Registry of Congenital Portosystemic Shunt (IRCPSS)	NCT06041906	Congenital Port...	Shunt Closure	1 Day -	University Hospital, Geneva
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone	NCT00004645	Acute Dissemina... Devic's Syndrom... Marburg's Varia... Balo's Concentr... Acute Transvers...	Plasma exchange	18 Years - 60 Years	Office of Rare Diseases (ORD)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: